Molecular Approaches to Detection of Bacteria in Critical Care Patients

  • J. L. Flanagan
  • S. V. Lynch
  • J. Wiener-Kronish


For over 100 years clinical medicine has relied on culture-based techniques to define infections in patients. However, over the past 30 years, it has become clear that culture-independent methods more completely describe both microbial diversity and community dynamics and the importance of such interactions in states of health and disease has been revealed [1, 2], Furthermore, the use of culture-based techniques has clouded our understanding of the pathogenesis of human infections. The concept that one species causes infection by entering the host, defeating the host’s defense system and multiplying to a threshold that allows it to cause injury is probably only applicable for a small subset of microbes, e.g., bioterror agents. The new emerging paradigm in microbial pathogenesis is that many organisms, such as Streptococcus pneumoniae, already exist in bacterial communities of the oro- and nasopharynx of most healthy individuals and that a change in their virulence gene expression and /or an increase in numbers permitting dissemination cause symptoms of infection [3]. The molecular signals that bring about these shifts in pathogen physiology are not fully understood; however, given the importance of bacterial cell-to-cell signaling (quorum sensing) it is possible that shifts in bacterial community composition may lead to emergence and dominance of pre-existing pathogenic species within the community This hypothesis is supported by the finding that within hours of their admission to the intensive care unit (ICU), critically ill patients exhibit dramatic changes in the bacterial communities colonizing their oro- and nasal pharynx [4, 5].


Microbial Community Bacterial Community Clone Library Dental Plaque Critical Care Patient 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zoetendal EG, Vaughan EE, de Vos WM (2006) A microbial world within us. Mol Microbiol 59:1639–1650PubMedCrossRefGoogle Scholar
  2. 2.
    Weng L, Rubin EM, Bristow J (2006) Application of sequence-based methods in human microbial ecology. Genome Res 16:316–322PubMedCrossRefGoogle Scholar
  3. 3.
    Johanson WG, Jr., Blackstock R, Pierce AK, Sanford JP (1970) The role of bacterial antagonism in pneumococcal colonization of the human pharynx. J Lab Clin Med 75:946–952PubMedGoogle Scholar
  4. 4.
    Johanson WG Jr, Higuchi JH, Chaudhuri TR, Woods DE (1980) Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis 121:55–63PubMedGoogle Scholar
  5. 5.
    Johanson WG, Pierce AK, Sanford JP (1970) Oropharyngeal ecology. N Engl J Med 282:815PubMedCrossRefGoogle Scholar
  6. 6.
    Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–1920PubMedCrossRefGoogle Scholar
  7. 7.
    Connon SA, Giovannoni SJ (2002) High-throughput methods for culturing microorganisms in very-low-nutrient media yield diverse new marine isolates. Appl Environ Microbiol 68:3878–3885PubMedCrossRefGoogle Scholar
  8. 8.
    Lupp C, Finlay BB (2005) Intestinal microbiota Curr Biol 15:R235–236CrossRefGoogle Scholar
  9. 9.
    Gill SR, Pop M, Deboy RT, et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355–1359PubMedCrossRefGoogle Scholar
  10. 10.
    Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070–11075PubMedCrossRefGoogle Scholar
  11. 11.
    Ordovas JM, Mooser V (2006) Metagenomics: the role of the microbiome in cardiovascular diseases. Curr Opin Lipidol 17:157–161PubMedCrossRefGoogle Scholar
  12. 12.
    Bjorksten B (2005) Evidence of probiotics in prevention of allergy and asthma. Curr Drug Targets Inflamm Allergy 4:599–604PubMedCrossRefGoogle Scholar
  13. 13.
    Bjorksten B (2005) Genetic and environmental risk factors for the development of food allergy. Curr Opin Allergy Clin Immunol 5:249–253PubMedCrossRefGoogle Scholar
  14. 14.
    Feldman C, Kassel M, Cantrell J, et al (1999) The presence and sequence of endotracheal tube colonization in patients undergoing mechanical ventilation. Eur Respir J 13:546–551PubMedCrossRefGoogle Scholar
  15. 15.
    Sottile FD, Marrie TJ, Prough DS, et al (1986) Nosocomial pulmonary infection: possible etiologic significance of bacterial adhesion to endotracheal tubes. Crit Care Med 14:265–270PubMedCrossRefGoogle Scholar
  16. 16.
    Johanson WG, Pierce AK, Sanford JP (1969) Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 281:1137–1140PubMedCrossRefGoogle Scholar
  17. 17.
    Scannapieco FA, Bush RB, Paju S (2003) Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann Periodontol 8:54–69PubMedCrossRefGoogle Scholar
  18. 18.
    El-Solh AA, Pietrantoni C, Bhat A, et al (2004) Colonization of dental plaques: a reservoir of respiratory pathogens for hospital-acquired pneumonia in institutionalized elders. Chest 126:1575–1582PubMedCrossRefGoogle Scholar
  19. 19.
    Scannapieco FA, Rethman MP (2003) The relationship between periodontal diseases and respiratory diseases. Dent Today 22:79–83PubMedGoogle Scholar
  20. 20.
    Socransky SS, Haffajee AD (2002) Dental biofilms: difficult therapeutic targets. Periodontol 2000 28:12–55CrossRefGoogle Scholar
  21. 21.
    Didilescu AC, Skaug N, Marica C, Didilescu C (2005) Respiratory pathogens in dental plaque of hospitalized patients with chronic lung diseases. Clin Oral Investig 9:141–147PubMedCrossRefGoogle Scholar
  22. 22.
    Munro CL, Grap MJ (2004) Oral health and care in the intensive care unit: state of the science. Am J Crit Care 13:25–33PubMedGoogle Scholar
  23. 23.
    El Solh AA, Pietrantoni C, Bhat A, Bhora M, Berbary E (2004) Indicators of potentially drug-resistant bacteria in severe nursing home-acquired pneumonia. Clin Infect Dis 39:474–480PubMedCrossRefGoogle Scholar
  24. 24.
    Paster BJ, Boches SK, Galvin JL, et al (2001) Bacterial diversity in human subgingival plaque. J Bacteriol 183:3770–3783PubMedCrossRefGoogle Scholar
  25. 25.
    Fourrier F, Dubois D, Pronnier P, et al (2005) Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit Care Med 33:1728–1735PubMedCrossRefGoogle Scholar
  26. 26.
    DeRiso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson AC (1996) Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and non-prophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 109:1556–1561PubMedGoogle Scholar
  27. 27.
    Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman MC (2001) Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect (Larchmt) 2:5–18CrossRefGoogle Scholar
  28. 28.
    Grap MJ, Munro CL, Elswick RK, Jr., Sessler CN, Ward KR (2004) Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. Heart Lung 33:83–91PubMedCrossRefGoogle Scholar
  29. 29.
    Koeman M, van der Ven AJ, Hak E, et al (2006) Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 173:1348–1355PubMedCrossRefGoogle Scholar
  30. 30.
    Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO (2002) Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care 11:567–570PubMedGoogle Scholar
  31. 31.
    Haffajee AD, Socransky SS (2006) Introduction to microbial aspects of periodontal biofilm communities, development and treatment. Periodontol 2000 42:7–12CrossRefGoogle Scholar
  32. 32.
    Armitage GC (2004) Basic features of biofilms — why are they difficult therapeutic targets? Ann R Australas Coll Dent Surg 17:30–34PubMedGoogle Scholar
  33. 33.
    Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39PubMedCrossRefGoogle Scholar
  34. 34.
    Fletcher JM, Nair SP, Ward JM, Henderson B, Wilson M (2001) Analysis of the effect of changing environmental conditions on the expression patterns of exported surface-associated proteins of the oral pathogen Actinobacillus actinomycetemcomitans. Microb Pathog 30:359–368PubMedCrossRefGoogle Scholar
  35. 35.
    Gillis RJ, White KG, Choi KH, Wagner VE, Schweizer HP, Iglewski BH (2005) Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 49:3858–3867PubMedCrossRefGoogle Scholar
  36. 36.
    Piddock LJ (2006) Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382–402PubMedCrossRefGoogle Scholar
  37. 37.
    Kumar PS, Leys EJ, Bryk JM, Martinez FJ, Moeschberger ML, Griffen AL (2006) Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol 44:3665–3673PubMedCrossRefGoogle Scholar
  38. 38.
    Suau A, Bonnet R, Sutren M, et al (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807PubMedGoogle Scholar
  39. 39.
    Ward DM, Weller R, Bateson MM (1990) 16S rRNA sequences reveal uncultured inhabitants of a well-studied thermal community. FEMS Microbiol Rev 6:105–115PubMedGoogle Scholar
  40. 40.
    Waar K, Degener JE, van Luyn MJ, Harmsen HJ (2005) Fluorescent in situ hybridization with specific DNA probes offers adequate detection of Enterococcus faecalis and Enterococcus faecium in clinical samples. J Med Microbiol 54:937–944PubMedCrossRefGoogle Scholar
  41. 41.
    Wagner M, Horn M, Daims H (2003) Fluorescence in situ hybridisation for the identification and characterisation of prokaryotes. Curr Opin Microbiol 6:302–309PubMedCrossRefGoogle Scholar
  42. 42.
    Purdy KJ, Nedwell DB, Embley TM (2003) Analysis of the sulfate-reducing bacterial and methanogenic archaeal populations in contrasting Antarctic sediments. Appl Environ Microbiol 69:3181–3191PubMedCrossRefGoogle Scholar
  43. 43.
    Bano N, Hollibaugh JT (2002) Phylogenetic composition of bacterioplankton assemblages from the Arctic Ocean. Appl Environ Microbiol 68:505–518PubMedCrossRefGoogle Scholar
  44. 44.
    Grabowski A, Nercessian O, Fayolle F, Blanchet D, Jeanthon C (2005) Microbial diversity in production waters of a low-temperature biodegraded oil reservoir. FEMS Microbiol Ecol 54:427–443PubMedCrossRefGoogle Scholar
  45. 45.
    Hutter G, Schlagenhauf U, Valenza G, et al (2003) Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens. Microbiology 149:67–75PubMedCrossRefGoogle Scholar
  46. 46.
    Eckburg PB, Bik EM, Bernstein CN, et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638PubMedCrossRefGoogle Scholar
  47. 47.
    Brodie EL, Desantis TZ, Joyner DC, et al (2006) Application of a high-density oligonucleotide microarray approach to study bacterial population dynamics during uranium reduction and reoxidation. Appl Environ Microbiol 72:6288–6298PubMedCrossRefGoogle Scholar
  48. 48.
    Schmidt HU, Kaliebe T, Poppinger J, Buhler C, Sander A (1996) Isolation of Bartonella quintana from an HIV-positive patient with bacillary angiomatosis. Eur J Clin Microbiol Infect Dis 15:736–741PubMedCrossRefGoogle Scholar
  49. 49.
    Hamilton KS, Standaert SM, Kinney MC (2004) Characteristic peripheral blood findings in human ehrlichiosis. Mod Pathol 17:512–517PubMedCrossRefGoogle Scholar
  50. 50.
    Wilson KH, Blitchington R, Frothingham R, Wilson JA (1991) Phylogeny of the Whipple’s-disease-associated bacterium. Lancet 338:474–475PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2007

Authors and Affiliations

  • J. L. Flanagan
    • 1
  • S. V. Lynch
    • 1
  • J. Wiener-Kronish
    • 1
  1. 1.Department of Anesthesia and Perioperative CareUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations